1. Antibiotic usage and prescribing policies in the intensive care unit

   • M. Emmerson

   Pages: S026 - S030

2. Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice

   • A. Liberati
   • R. D'Amico
   • E. Telaro

   Pages: S038 - S044

3. The detection and interpretation of endotoxaemia

   • J. Cohen

   Pages: S051 - S056

4. Monitoring and evaluating clinical trials data

   • J. Whitehead

   Pages: S084 - S088

5. Cytokine and cytokine receptor polymorphisms in infectious disease

   • S. J. H. van Deventer

   Pages: S098 - S102

6. Immunomodulatory therapies in sepsis

   • W. J. Kox
   • T. Volk
   • H. -D. Volk

   Pages: S124 - S128

7. Mechanisms of resistance to antibiotics

   • P. M. Hawkey

   Pages: S009 - S013

8. Prevention and control of infections in intensive care

   • G. Scott

   Pages: S022 - S025

9. Susceptibility to critical illness: reserve, response and therapy

   • J. F. Bion

   Pages: S057 - S063

10. Intravascular catheter-related sepsis – novel methods of prevention

    • T. Elliott

    Pages: S045 - S050

11. Neutropenia: clinical implications and modulation

    • M. P. Glauser

    Pages: S103 - S110

12. Endotoxin immunization

    • R. Stephens
    • M. Mythen

    Pages: S129 - S136

13. Gene therapy for acute lung injury

    • K. L. Brigham
    • A. A. Stecenko

    Pages: S119 - S123

14. Microbial resistance: lessons from the EPIC study

    • J. -L. Vincent

    Pages: S003 - S008

15. Epidemiology of antibiotic resistance

    • D. M. Livermore

    Pages: S014 - S021

16. Introduction – Infection and critical illness: genetic and environmental aspects of susceptibility and resistance

    • J. F. Bion
    • C. Brun-Buisson

    Pages: S001 - S002

17. The epidemiology of the systemic inflammatory response

    • C. Brun-Buisson

    Pages: S064 - S074

18. Leukocytes: friend or foe

    • G Bellingan

    Pages: S111 - S118

19. Cardiac reserve: linking physiology and genetics

    • H. Montgomery

    Pages: S137 - S144

20. Ventilator associated pneumonia: perspectives on the burden of illness

    • D. Cook

    Pages: S031 - S037

21. Clinical trials of mediator-directed therapy in sepsis: what have we learned?

    • J. C. Marshall

    Pages: S075 - S083

22. Genetic dissection of the molecular pathogenesis of severe infection

    • D. Kwiatkowski

    Pages: S089 - S097